Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 2/20 | 0.71 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.61 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 7/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19860126 | 0.93 | PRMT3 (0.65) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL2162616 | 0.88 | IMPDH2 (0.70) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL3566775 | 0.87 | PRMT3 (0.72) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL19860120 | 0.85 | PRMT3 (0.53) | PRMT3IMPDH2NOTUMROCK2 | |
| SCHEMBL19860119 | 0.84 | ROCK2 (0.53) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL2164137 | 0.84 | PRMT3 (0.69) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL24735962 | 0.83 | IMPDH2 (0.69) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL14124306 | 0.82 | PRMT3 (0.66) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL19860110 | 0.82 | IMPDH2 (0.59) | PRMT3IMPDH2NOTUMROCK1ROCK2 | |
| SCHEMBL3598434 | 0.82 | IMPDH2 (0.69) | PRMT3IMPDH2NOTUMROCK1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9890123-B2 | 6-aminoisoquinoline compounds | AERIE PHARMACEUTICALS, INC. (US) | 2018-02-13 | — | — | US | disclosed |